The MAOA rs6323 polymorphism—in LD with rs979605—was previously examined in association with response to ATD treatment in several contexts, including rapid versus delayed response and response in placebo- versus ATD-treated individuals [16,22]. The gene discussed is MAOA; the disease is Jeune syndrome.